Literature DB >> 18521329

Which Soft Tissue Sarcoma Patients with Lung Metastases Should not Undergo Pulmonary Resection?

Albertus N van Geel1, Joost Rm van Der Sijp, Paul Im Schmitz.   

Abstract

Using the second best method of meta-analysis it is significantly shown that patients with an interval of less than 7 months between diagnosis of soft tissue sarcoma and lung surgery for metastases do not benefit.

Entities:  

Year:  2002        PMID： 18521329      PMCID： PMC2395478          DOI： 10.1155/S1357714X02000178

Source DB:  PubMed          Journal:  Sarcoma        ISSN： 1357-714X


  21 in total

1.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

Authors:  M K Parmar; V Torri; L Stewart
Journal:  Stat Med       Date:  1998-12-30       Impact factor: 2.373

2.  Long-term results after repeated surgical removal of pulmonary metastases.

Authors:  D Kandioler; E Krömer; H Tüchler; A End; M R Müller; E Wolner; F Eckersberger
Journal:  Ann Thorac Surg       Date:  1998-04       Impact factor: 4.330

3.  Video-assisted approach for transxiphoid bilateral lung metastasectomy.

Authors:  T C Mineo; E Pompeo; V Ambrogi; C Pistolese
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

4.  Diagnostic and therapeutic video-assisted thoracic surgery resection of pulmonary metastases.

Authors:  J C Lin; R J Wiechmann; M F Szwerc; S R Hazelrigg; P F Ferson; K S Naunheim; R J Keenan; A P Yim; E Rendina; T DeGiacomo; G F Coloni; F Venuta; R S Macherey; S Bartley; R J Landreneau
Journal:  Surgery       Date:  1999-10       Impact factor: 3.982

5.  Aggressive pulmonary metastasectomy for soft tissue sarcomas.

Authors:  T Ueda; A Uchida; K Kodama; O Doi; K Nakahara; Y Fujii; Y Komatsubara; K Ono
Journal:  Cancer       Date:  1993-09-15       Impact factor: 6.860

6.  Median sternotomy: the preferred incision for resection of lung metastases.

Authors:  A H van der Veen; A N van Geel; W C Hop; T Wiggers
Journal:  Eur J Surg       Date:  1998-07

7.  Survival after pulmonary metastasectomy in soft tissue sarcoma. Prognostic factors in 214 patients.

Authors:  P F Choong; D J Pritchard; M G Rock; F H Sim; F J Frassica
Journal:  Acta Orthop Scand       Date:  1995-12

8.  Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis.

Authors:  G T Verazin; J A Warneke; D L Driscoll; C Karakousis; N J Petrelli; H Takita
Journal:  Arch Surg       Date:  1992-12

Review 9.  Pulmonary metastasectomy for soft tissue sarcomas: is it justified?

Authors:  D B Frost
Journal:  J Surg Oncol       Date:  1995-06       Impact factor: 3.454

10.  Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients.

Authors:  A N van Geel; U Pastorino; K W Jauch; I R Judson; F van Coevorden; J M Buesa; O S Nielsen; A Boudinet; T Tursz; P I Schmitz
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860
View more
  4 in total

1.  Pulmonary metastasectomy in soft tissue sarcomas: a systematic review.

Authors:  Davor Stamenovic; Peter Hohenberger; Eric Roessner
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

Review 2.  The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?

Authors:  P H Patel; D Palma; F McDonald; A C Tree
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-06-08       Impact factor: 4.126

3.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Authors:  Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

4.  Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data.

Authors:  Tom Treasure; Francesca Fiorentino; Marco Scarci; Henrik Møller; Martin Utley
Journal:  BMJ Open       Date:  2012-10-08       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.